SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-028853
Filing Date
2023-08-15
Accepted
2023-08-15 09:00:23
Documents
13
Period of Report
2023-08-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37555
2 SHUTTLE PHARMACEUTICALS PROVIDES SECOND QUARTER 2023 CORPORATE UPDATE ex99-1.htm EX-99.1 18327
  Complete submission text file 0001493152-23-028853.txt   235186

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT shph-20230815.xsd EX-101.SCH 3030
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT shph-20230815_lab.xml EX-101.LAB 34240
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT shph-20230815_pre.xml EX-101.PRE 22369
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3433
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 231173354
SIC: 2834 Pharmaceutical Preparations